Manhattan Associates Insider Sale: James Gantt Disposes of 2,300 Shares
Rhea-AI Filing Summary
Manhattan Associates insider James Stewart Gantt reported two open-market stock sales on 08/28/2025 totaling 2,300 shares at prices of $218.795 and $218.62. After these transactions the reporting person beneficially owned 49,168 shares. The Form 4 was signed by an attorney-in-fact on 09/02/2025. The filing identifies Gantt as an EVP, Professional Services and an officer of Manhattan Associates (MANH).
Positive
- Transactions were properly reported on a Form 4 with transaction dates and post-sale holdings disclosed
- Post-transaction beneficial ownership is clearly stated as 49,168 shares
Negative
- Officer disposed of 2,300 shares on 08/28/2025, which reduces insider ownership
- No information provided on whether trades were part of a Rule 10b5-1 trading plan
Insights
TL;DR: Officer sold a modest number of shares; total holdings remain material but reduced.
The filing discloses two sell transactions totaling 2,300 shares executed on 08/28/2025 at roughly $218.62–$218.80 per share. Post-transaction beneficial ownership is 49,168 shares. For an analyst, these are routine insider dispositions reported under Section 16; the size of the sale relative to total outstanding shares is not specified in the filing, so market impact cannot be assessed from this document alone.
TL;DR: Properly reported officer sales; documentation appears complete and timely.
The Form 4 indicates the reporting person is an officer (EVP, Professional Services) and that the transactions were reported via a single reporting person filing. The form includes signature via attorney-in-fact and provides transaction codes and post-sale holdings. No indications of planned trading programs or derivative activity are included in this filing.
FAQ
What insider activity did MANH officer James Stewart Gantt report on Form 4?
How many Manhattan Associates shares did the reporting person own after the transactions?
What role does the reporting person hold at MANH?
When was the Form 4 signed and by whom?
Were any derivative securities or stock purchases reported on this Form 4?